EU MDR Clinical & Postmarket Surveillance Strategies

The EU MDR requires significantly larger amounts and different types of both premarket and postmarket device safety and performance data. In addition to more rigorous clinical information and active collection and analysis of postmarket experiences – for legacy devices as well as new products – new processes and governance will be needed to support this assessment and ongoing file updates. Registration will open soon.